FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to therapy and rehabilitation, can be used to increase the effectiveness of rehabilitation treatment of patients suffering COVID-19. Drug therapy is carried out with glucocorticosteroids, low-molecular heparins and other drugs prescribed by the standard. Additionally, hypobaric oxygenation sessions are prescribed with isopression mode from 0.85 ata to 0.9 ata for 40–50 minutes, compression and decompression are performed smoothly for 10-25 minutes, session duration is from 60–75 minutes. Immediately after the hypobarium session, a hyperbaric oxygenation session is performed at an absolute pressure of 1.3–1.6 atmospheres absolute, the isopression period is from 40 to 80 minutes, exposure to the highest O2 pressure, smooth compression and decompression for 2–5 minutes; therapeutic course is 10 sessions.
EFFECT: method provides fast stabilization of the condition, reduced level of inflammation markers, elimination of cough, shortness of breath, reduced intensity of anxiety and depression, asthenisation, improved cognitive functions.
2 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SELECTING DOSING REGIMEN OF HYPERBARIC THERAPY FOR PATIENTS WITH COVID-ASSOCIATED PNEUMONIA | 2023 |
|
RU2826470C1 |
METHOD FOR MEDICAL REHABILITATION OF PATIENTS WITH VIRAL PNEUMONIA ASSOCIATED WITH CORONAVIRUS INFECTION COVID-19 | 2022 |
|
RU2772211C1 |
METHOD OF COMPLEX THERAPY OF PATIENTS WITH ACUTE PURULENT PYELONEPHRITIS WITH APPLICATION OF HYPOBARIC HYPEROXYGENATION | 2007 |
|
RU2335287C1 |
METHOD OF TREATMENT OF PATIENTS WHO HAVE HAD NEW CORONAVIRUS INFECTION WITH LUNG DAMAGE IN THE EARLY RECOVERY PERIOD | 2022 |
|
RU2801234C1 |
METHOD OF HYPERBARIC OXYGENATION THERAPY MODE SELECTION IN TREATMENT OF PATIENTS WITH LOWER LIMBS ISCHEMIA | 2007 |
|
RU2362482C1 |
METHOD OF TREATING PATIENTS WITH NOVEL CORONAVIRUS INFECTION COVID-19 WITH SPONTANEOUS RESPIRATION | 2023 |
|
RU2824264C1 |
METHOD FOR TREATING PATIENTS WITH A NEW CORONAVIRUS INFECTION COVID-19 WITH HIGH-FLOW OXYGENATION | 2022 |
|
RU2787175C1 |
METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 |
|
RU2803002C1 |
METHOD FOR DIFFERENTIATED PRESCRIPTION OF HYPERBARIC OXYGENATION AT PULMONARY CANCER | 2003 |
|
RU2255338C1 |
METHOD FOR TREATING PATIENTS HAVING AUTOIMMUNE DISEASES | 1994 |
|
RU2105555C1 |
Authors
Dates
2024-06-25—Published
2023-10-12—Filed